This initiative funds projects that develop and test highly innovative experimental or computational methods to accelerate rare disease diagnosis. The focus is on reimagining tools and analytical approaches to identify causal genes or variants underlying rare genetic disorders, aiming for transformative improvements in diagnostic capabilities.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, small businesses, for-profit organizations, and foreign entities. Both domestic and foreign organizations, including international collaborations, may apply.
